Medpace Holdings Inc

MEDP: XNAS (USA)
View Stock Summary
Morningstar Rating for StocksFair ValueEconomic MoatCapital Allocation
LOCK|T>LOCK|<q%KLOCK|vGbMmp

Medpace Earnings: Stock Soars 55% on Significantly Higher Backlog Conversion and Fewer Cancellations

Medpace's second-quarter revenue increased 14% from the prior year, and its backlog conversion rate was 21%. Management increased its 2025 revenue guidance by 13% at the midpoint and raised its net income guidance by nearly 7%. Shares soared 55% on the better-than-expected results.

Sponsor Center